Vanguard Group Inc Sangamo Therapeutics, Inc Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 9,374,728 shares of SGMO stock, worth $4.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,374,728

Previous 9,374,728 -0.0%

Holding current value

$4.31 Million

Previous $9.56 Million 35.3%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$0.78 - $2.87 $173,978 - $640,150	-223,049 Reduced 2.32%	9,374,728 $9.56 Million
Q3 2024 Nov 13, 2024	SELL	$0.32 - $1.1 $736,204 - $2.53 Million	-2,300,640 Reduced 19.34%	9,597,777 $8.25 Million
Q2 2024 Aug 13, 2024	SELL	$0.36 - $0.65 $108,702 - $196,268	-301,951 Reduced 2.47%	11,898,417 $4.28 Million
Q1 2024 May 10, 2024	SELL	$0.42 - $1.38 $167,479 - $550,290	-398,761 Reduced 3.16%	12,200,368 $8.17 Million
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $20,665 - $43,396	68,884 Added 0.55%	12,599,129 $6.8 Million
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $76,463 - $193,794	131,833 Added 1.06%	12,530,245 $7.52 Million
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $2.2 Million - $3.45 Million	-1,982,497 Reduced 13.79%	12,398,412 $16.1 Million
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $556,598 - $1.23 Million	335,300 Added 2.39%	14,380,909 $25.3 Million
Q4 2022 Feb 10, 2023	BUY	$2.77 - $5.07 $3.64 Million - $6.66 Million	1,314,500 Added 10.33%	14,045,609 $44.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $5.15 Million - $7.71 Million	1,205,951 Added 10.46%	12,731,109 $62.4 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.21 $4.56 Million - $8.63 Million	1,389,297 Added 13.71%	11,525,158 $47.7 Million
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $4.16 Million - $6.22 Million	795,306 Added 8.51%	10,135,861 $58.9 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $1.06 Million - $1.59 Million	145,220 Added 1.58%	9,340,555 $70.1 Million
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $811,593 - $1.08 Million	90,077 Added 0.99%	9,195,335 $82.9 Million
Q2 2021 Aug 13, 2021	BUY	$10.17 - $12.64 $92.6 Million - $115 Million	9,105,258 New	9,105,258 $109 Million

Others Institutions Holding SGMO

# of Institutions

137

Shares Held

51.2M

Call Options Held

2.17M

Put Options Held

1.82M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $72M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Sangamo Therapeutics, Inc Transaction History